Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 0.08
WOOF's Cash to Debt is ranked lower than
77% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. WOOF: 0.08 )
Ranked among companies with meaningful Cash to Debt only.
WOOF' s Cash to Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.13 Max: No Debt
Current: 0.08
Equity to Asset 0.49
WOOF's Equity to Asset is ranked higher than
53% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. WOOF: 0.49 )
Ranked among companies with meaningful Equity to Asset only.
WOOF' s Equity to Asset Range Over the Past 10 Years
Min: -0.17  Med: 0.48 Max: 0.59
Current: 0.49
-0.17
0.59
Interest Coverage 14.29
WOOF's Interest Coverage is ranked higher than
63% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 6.25 vs. WOOF: 14.29 )
Ranked among companies with meaningful Interest Coverage only.
WOOF' s Interest Coverage Range Over the Past 10 Years
Min: 5.46  Med: 10.97 Max: 15.55
Current: 14.29
5.46
15.55
F-Score: 7
Z-Score: 4.50
M-Score: -2.54
WACC vs ROIC
7.60%
10.49%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 15.78
WOOF's Operating margin (%) is ranked higher than
79% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. WOOF: 15.78 )
Ranked among companies with meaningful Operating margin (%) only.
WOOF' s Operating margin (%) Range Over the Past 10 Years
Min: 5.47  Med: 15.23 Max: 20.17
Current: 15.78
5.47
20.17
Net-margin (%) 9.96
WOOF's Net-margin (%) is ranked higher than
74% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 4.79 vs. WOOF: 9.96 )
Ranked among companies with meaningful Net-margin (%) only.
WOOF' s Net-margin (%) Range Over the Past 10 Years
Min: 2.68  Med: 8.94 Max: 10.73
Current: 9.96
2.68
10.73
ROE (%) 17.89
WOOF's ROE (%) is ranked higher than
75% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.90 vs. WOOF: 17.89 )
Ranked among companies with meaningful ROE (%) only.
WOOF' s ROE (%) Range Over the Past 10 Years
Min: 3.98  Med: 14.17 Max: 28.56
Current: 17.89
3.98
28.56
ROA (%) 8.88
WOOF's ROA (%) is ranked higher than
76% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. WOOF: 8.88 )
Ranked among companies with meaningful ROA (%) only.
WOOF' s ROA (%) Range Over the Past 10 Years
Min: 2.23  Med: 7.52 Max: 11.28
Current: 8.88
2.23
11.28
ROC (Joel Greenblatt) (%) 78.03
WOOF's ROC (Joel Greenblatt) (%) is ranked higher than
84% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 17.56 vs. WOOF: 78.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WOOF' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 23.39  Med: 68.40 Max: 116.35
Current: 78.03
23.39
116.35
Revenue Growth (3Y)(%) 10.50
WOOF's Revenue Growth (3Y)(%) is ranked higher than
63% of the 173 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. WOOF: 10.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WOOF' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 8.70 Max: 130.9
Current: 10.5
0
130.9
EBITDA Growth (3Y)(%) 40.60
WOOF's EBITDA Growth (3Y)(%) is ranked higher than
94% of the 142 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. WOOF: 40.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WOOF' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 8.90 Max: 225.3
Current: 40.6
0
225.3
EPS Growth (3Y)(%) 70.80
WOOF's EPS Growth (3Y)(%) is ranked higher than
94% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. WOOF: 70.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WOOF' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 7.10 Max: 102.2
Current: 70.8
0
102.2
» WOOF's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-29)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

WOOF Guru Trades in Q1 2015

Louis Moore Bacon 75,000 sh (New)
Caxton Associates 10,000 sh (New)
Larry Robbins 12,800,370 sh (unchged)
Third Avenue Management 153,881 sh (unchged)
Joel Greenblatt 147,419 sh (-1.34%)
Jim Simons 1,389,200 sh (-12.08%)
» More
Q2 2015

WOOF Guru Trades in Q2 2015

Pioneer Investments 74,934 sh (New)
Third Avenue Management 153,881 sh (unchged)
Larry Robbins 12,800,370 sh (unchged)
Louis Moore Bacon Sold Out
Joel Greenblatt Sold Out
Caxton Associates Sold Out
Jim Simons 1,379,600 sh (-0.69%)
» More
Q3 2015

WOOF Guru Trades in Q3 2015

Steven Cohen 310,800 sh (New)
Ray Dalio 8,198 sh (New)
Joel Greenblatt 13,809 sh (New)
Pioneer Investments 83,822 sh (+11.86%)
Jim Simons 1,424,200 sh (+3.23%)
Third Avenue Management 153,935 sh (+0.04%)
Larry Robbins 8,073,670 sh (-36.93%)
» More
Q4 2015

WOOF Guru Trades in Q4 2015

Joel Greenblatt 20,165 sh (+46.03%)
Ray Dalio Sold Out
Pioneer Investments 81,787 sh (-2.43%)
Jim Simons 1,251,900 sh (-12.10%)
Third Avenue Management 132,590 sh (-13.87%)
Larry Robbins 6,320,549 sh (-21.71%)
Steven Cohen 126,300 sh (-59.36%)
» More
» Details

Insider Trades

Latest Guru Trades with WOOF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.62
WOOF's P/E(ttm) is ranked higher than
54% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. WOOF: 23.62 )
Ranked among companies with meaningful P/E(ttm) only.
WOOF' s P/E(ttm) Range Over the Past 10 Years
Min: 10.27  Med: 21.82 Max: 56.67
Current: 23.62
10.27
56.67
Forward P/E 20.04
WOOF's Forward P/E is ranked lower than
69% of the 74 Companies
in the Global Medical Care industry.

( Industry Median: 16.81 vs. WOOF: 20.04 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 23.62
WOOF's PE(NRI) is ranked higher than
53% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. WOOF: 23.62 )
Ranked among companies with meaningful PE(NRI) only.
WOOF' s PE(NRI) Range Over the Past 10 Years
Min: 10.24  Med: 21.80 Max: 56.8
Current: 23.62
10.24
56.8
Price/Owner Earnings (ttm) 22.10
WOOF's Price/Owner Earnings (ttm) is ranked higher than
60% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 26.24 vs. WOOF: 22.10 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
WOOF' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 9.26  Med: 19.61 Max: 48.23
Current: 22.1
9.26
48.23
P/B 3.91
WOOF's P/B is ranked lower than
70% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. WOOF: 3.91 )
Ranked among companies with meaningful P/B only.
WOOF' s P/B Range Over the Past 10 Years
Min: 1.23  Med: 2.66 Max: 8.11
Current: 3.91
1.23
8.11
P/S 2.42
WOOF's P/S is ranked lower than
67% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.56 vs. WOOF: 2.42 )
Ranked among companies with meaningful P/S only.
WOOF' s P/S Range Over the Past 10 Years
Min: 0.94  Med: 1.74 Max: 3.42
Current: 2.42
0.94
3.42
PFCF 23.42
WOOF's PFCF is ranked lower than
54% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 21.39 vs. WOOF: 23.42 )
Ranked among companies with meaningful PFCF only.
WOOF' s PFCF Range Over the Past 10 Years
Min: 10.45  Med: 18.57 Max: 37.05
Current: 23.42
10.45
37.05
POCF 16.40
WOOF's POCF is ranked lower than
56% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.93 vs. WOOF: 16.40 )
Ranked among companies with meaningful POCF only.
WOOF' s POCF Range Over the Past 10 Years
Min: 7.26  Med: 12.67 Max: 26.9
Current: 16.4
7.26
26.9
EV-to-EBIT 15.75
WOOF's EV-to-EBIT is ranked higher than
62% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 19.52 vs. WOOF: 15.75 )
Ranked among companies with meaningful EV-to-EBIT only.
WOOF' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.3  Med: 14.00 Max: 29.5
Current: 15.75
7.3
29.5
EV-to-EBITDA 12.94
WOOF's EV-to-EBITDA is ranked higher than
53% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 13.44 vs. WOOF: 12.94 )
Ranked among companies with meaningful EV-to-EBITDA only.
WOOF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.5  Med: 11.50 Max: 18.3
Current: 12.94
6.5
18.3
PEG 1.76
WOOF's PEG is ranked higher than
64% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. WOOF: 1.76 )
Ranked among companies with meaningful PEG only.
WOOF' s PEG Range Over the Past 10 Years
Min: 0.34  Med: 1.31 Max: 73.79
Current: 1.76
0.34
73.79
Shiller P/E 41.60
WOOF's Shiller P/E is ranked lower than
73% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 30.32 vs. WOOF: 41.60 )
Ranked among companies with meaningful Shiller P/E only.
WOOF' s Shiller P/E Range Over the Past 10 Years
Min: 14.95  Med: 26.19 Max: 55.36
Current: 41.6
14.95
55.36
Current Ratio 1.21
WOOF's Current Ratio is ranked lower than
56% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.36 vs. WOOF: 1.21 )
Ranked among companies with meaningful Current Ratio only.
WOOF' s Current Ratio Range Over the Past 10 Years
Min: 0.99  Med: 1.58 Max: 2.67
Current: 1.21
0.99
2.67
Quick Ratio 0.99
WOOF's Quick Ratio is ranked lower than
64% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. WOOF: 0.99 )
Ranked among companies with meaningful Quick Ratio only.
WOOF' s Quick Ratio Range Over the Past 10 Years
Min: 0.82  Med: 1.40 Max: 2.48
Current: 0.99
0.82
2.48
Days Inventory 11.71
WOOF's Days Inventory is ranked higher than
64% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 17.59 vs. WOOF: 11.71 )
Ranked among companies with meaningful Days Inventory only.
WOOF' s Days Inventory Range Over the Past 10 Years
Min: 10.06  Med: 12.37 Max: 14.23
Current: 11.71
10.06
14.23
Days Sales Outstanding 13.21
WOOF's Days Sales Outstanding is ranked higher than
88% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 44.25 vs. WOOF: 13.21 )
Ranked among companies with meaningful Days Sales Outstanding only.
WOOF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.51  Med: 13.06 Max: 16.51
Current: 13.21
11.51
16.51
Days Payable 10.21
WOOF's Days Payable is ranked lower than
89% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 42.56 vs. WOOF: 10.21 )
Ranked among companies with meaningful Days Payable only.
WOOF' s Days Payable Range Over the Past 10 Years
Min: 9.68  Med: 11.29 Max: 12.28
Current: 10.21
9.68
12.28

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.84
WOOF's Price/Projected FCF is ranked lower than
53% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. WOOF: 1.84 )
Ranked among companies with meaningful Price/Projected FCF only.
WOOF' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.84  Med: 1.65 Max: 8.43
Current: 1.84
0.84
8.43
Price/DCF (Earnings Based) 2.21
WOOF's Price/DCF (Earnings Based) is ranked lower than
81% of the 26 Companies
in the Global Medical Care industry.

( Industry Median: 1.73 vs. WOOF: 2.21 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.41
WOOF's Price/Median PS Value is ranked lower than
73% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. WOOF: 1.41 )
Ranked among companies with meaningful Price/Median PS Value only.
WOOF' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.63  Med: 1.08 Max: 1.88
Current: 1.41
0.63
1.88
Price/Peter Lynch Fair Value 2.27
WOOF's Price/Peter Lynch Fair Value is ranked lower than
51% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 2.21 vs. WOOF: 2.27 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WOOF' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.66  Med: 1.45 Max: 2.09
Current: 2.27
0.66
2.09
Earnings Yield (Greenblatt) (%) 6.37
WOOF's Earnings Yield (Greenblatt) (%) is ranked higher than
70% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. WOOF: 6.37 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WOOF' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.4  Med: 7.20 Max: 13.8
Current: 6.37
3.4
13.8
Forward Rate of Return (Yacktman) (%) 13.98
WOOF's Forward Rate of Return (Yacktman) (%) is ranked higher than
62% of the 102 Companies
in the Global Medical Care industry.

( Industry Median: 11.10 vs. WOOF: 13.98 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WOOF' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -3.4  Med: 14.20 Max: 104
Current: 13.98
-3.4
104

More Statistics

Revenue(Mil) $2198
EPS $ 2.67
Beta0.90
Short Percentage of Float1.01%
52-Week Range $44.00 - 64.98
Shares Outstanding(Mil)80.77

Analyst Estimate

Dec16 Dec17
Revenue(Mil) 2,404 2,556
EPS($) 2.78 3.15
EPS without NRI($) 2.78 3.15

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:MD, ASX:SHL, FRA:CLS1, NAS:ACHC, SZSE:300015 » details
Traded in other countries:VCA.Germany,
VCA Inc, formerly known as VCA Antech Inc was formed in 1986 as a Delaware corporation and during the 1990s established a position in the animal hospital and veterinary diagnostic laboratory markets through both internal growth and acquisitions. It is a national animal healthcare company operating in the United States and Canada. It provides veterinary services and diagnostic testing to support veterinary care and sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company operates in four segments: animal hospitals, veterinary diagnostic laboratories, veterinary medical technology and Vetstreet. The Companys animal hospitals offer a full range of general medical and surgical services for companion animals. Its animal hospitals treat diseases and injuries, provide pharmaceutical products and perform a variety of pet-wellness programs, including health examinations, diagnostic testing, vaccinations, spaying, neutering and dental care. At December 31, 2013, it operated 609 animal hospitals throughout 41 states and 4 Canadian provinces. The Company operates a full-service veterinary diagnostic laboratory network serving all 50 states and certain areas in Canada. Its laboratory network provides sophisticated testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment and prevention of diseases and other conditions affecting animals. At December 31, 2013, it operated 56 laboratories of various sizes located strategically throughout the United States and Canada. The Companys Medical Technology business sells digital radiography and ultrasound imaging equipment, provides education and training on the use of that equipment, provides consulting and mobile imaging services, and sells software and ancillary services to the veterinary market. The Company's sales agents market and sell its products and services to veterinary hospitals and universities. It mainly directs its marketing efforts toward its existing clients through customer education efforts. It license its proprietary software, TruDR. TruDR allows for the capture of digital x-ray images and transmits those images to a computer containing archiving and reviewing software. It also provide mobile imaging, consulting, education and training services to its customers. The companion animal healthcare industry is competitive and subject to continual change in the manner in which services are delivered and providers are selected. Certain states have laws that prohibit business corporations from providing, or holding themselves out as providers of, veterinary medical care.
» More Articles for WOOF

Headlines

Articles On GuruFocus.com
2 Picks in Growing Pet Industry Jan 30 2016 
GuruFocus Real Time Picks of the Week Jun 06 2014 
Morning Coffee: Real-Time Picks May 30 2014 
Building a Technical Swing-Trade with VCA Antech (WOOF) Oct 17 2013 
Arnold Van Den Berg Trims Staples, Sells Out of Dell and Others - Q4 Updates Jan 09 2013 
Weekly Guru Bargains Highlights: WOOF, VPRT, IBN, PHG, CTRP Oct 15 2011 
Arnold Van Den Berg's Top 5 Third-Quarter Buys Oct 11 2011 
Earning Power: Return on Something Sep 23 2011 
Free Cash Free Calculation for Serial Acquirers: VCA Antech Sep 24 2010 
VCA Antech Inc. (WOOF) COO & Senior Vice President Arthur J Antin sells 40,000 Shares Dec 18 2009 

More From Other Websites
VCA Inc. to Present at Jefferies 2016 Healthcare Conference May 04 2016
VCA Inc. to Present at Jefferies 2016 Healthcare Conference May 04 2016
VCA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 03 2016
VCA Inc. Announces Closing of Acquisition of Majority Interest in Companion Animal Practices, North... May 02 2016
VCA Inc. Announces Closing of Acquisition of Majority Interest in Companion Animal Practices, North... May 02 2016
ETF’s with exposure to VCA, Inc. : April 29, 2016 Apr 29 2016
VCA, Inc. :WOOF-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 28 2016
Fed Holds Rates Steady; Facebook, PayPal Report Apr 27 2016
Edited Transcript of WOOF earnings conference call or presentation 27-Apr-16 1:00pm GMT Apr 27 2016
VCA Inc. Reports First Quarter 2016 Results and Increases Financial Guidance for 2016 Apr 27 2016
VCA tops Street 1Q forecasts Apr 27 2016
VCA tops Street 1Q forecasts Apr 27 2016
VCA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and... Apr 27 2016
VCA Inc. Reports First Quarter 2016 Results and Increases Financial Guidance for 2016 Apr 27 2016
Q1 2016 VCA Inc Earnings Release - 08:00 am ET Apr 27 2016
VCA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Apr 18 2016
VCA Inc. to Present at Bank of America Merrill Lynch 2016 Health Care Conference Apr 07 2016
VCA Inc. to Present at Bank of America Merrill Lynch 2016 Health Care Conference Apr 07 2016
Coverage initiated on VCA Antech by CL King Apr 01 2016
VCA Inc. to Report First Quarter 2016 Financial Results Mar 23 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK